Patent filing intended to strengthen PharmaTher's peptide formulation capabilities for PharmaPatch™ while complementing PatchPrint™ as part of the Company's broader microneedle patch development and ...

Conventional wisdom holds that diversified firms’ ability to shift resources across businesses creates competitive advantage.

Gelatine Sculpt is positioned within the evolving landscape of weight management solutions as a structured, liquid-based ...

Rustam Gilfanov is an entrepreneur and researcher whose career unites industrial efficiency, scientific precision, and ...

After shedding expensive commercial infrastructure and pivoting to a partnership model, the company is now positioning its ...

CTEXLI approved by FDA for CTX; LIVMARLI approved in Japan for PFIC and Alagille syndrome with partner Takeda; and a single ...

Leaders running the leadership OS begin not with the message they want to deliver but with the experience they want the ...

Company outlines near-term pharmacokinetic milestones, highlights amorphous formulation strategy, and announces planned global patent filing ...

Demand for bitcoin as a corporate treasury asset has almost completely disappeared for all but Strategy, according to crypto data provider CryptoQuant. Over the past 30 days, bitcoin accumulators ...

Strategy launches new capital plan to buy more Bitcoin The company also bought more Bitcoin on Monday, worth billions Saylor turns equity markets into a Bitcoin accumulation engine Michael Saylor's ...

It's not out of the realm of possibility that Strategy (MSTR) could be the owner of 1 million bitcoin — or nearly 5% of the 21 million bitcoin that will ever be created — by the end of 2026. The ...